Mold-Tek Packaging profit jumps 36% on volume growth

For investors, the key point is that the earnings beat was driven by real operating momentum, not just accounting gains. Sales volume rose 10.09% from a year earlier, helped by a 26.3% increase in pharma packaging volumes and 23.7% growth in food and FMCG packaging, more than offsetting a 12.32% drop in lubricants packaging.

That mix matters because pharma and FMCG are usually seen as higher-quality demand streams for packaging suppliers, offering better visibility than more cyclical industrial segments. The company said the quarter was still marked by sharp raw material price increases and material availability constraints tied to geopolitical disruptions, underscoring that margin pressure has not gone away.

Technical indicators also point to strong near-term momentum, with the stock’s relative strength index in overbought territory and the price trading near the upper Bollinger Band. That leaves the shares vulnerable to profit-taking even after the results-driven jump, which helps explain why brokers are urging existing holders to stay invested while new buyers wait for a pullback.

Choice Broking’s Sumeet Bagadia said current holders can continue to hold the stock with a long-term view, but should avoid chasing it at current levels, while Kantilal Chhaganlal Securities’ Mahesh M Ojha said the stock still has room to rise toward ₹328, ₹340 and above ₹360 if momentum holds.

The next catalyst is whether Mold-Tek can keep volume growth intact and defend margins in the December quarter, especially if raw material costs stay elevated and the geopolitical backdrop remains unsettled.